Overactive Bladder

Improving Clinical Outcomes for Women with Overactive Bladder and Urinary Retention Symptoms: A Comparison of Motor Response Voltages (1 - 9) during Stage 1 Sacral Neuromodulation. April 17, 2018

Efficacy of pelvic floor muscle training in women with overactive bladder syndrome: a systematic review. April 16, 2018

THE TELOCYTES/MYOFIBROBLASTS 3-D NETWORK FORMS A STRETCH RECEPTOR IN THE HUMAN BLADDER MUCOSA. IS THIS STRUCTURE INVOLVED IN THE DETRUSOR OVERACTIVE DISEASES? April 15, 2018

Clinical features and association of bladder ultrasound findings and uroflowmetry with healing period of overactive bladder in children. April 15, 2018

Selective bladder denervation for overactive bladder (OAB) syndrome: From concept to healing outcomes using the ovine model. April 14, 2018

Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study. April 10, 2018

Are the Electronic and Paper Questionnaires Equivalent in Assessing Patients with Overactive Bladder? April 10, 2018

Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder. April 1, 2018

Improvement of overactive bladder symptoms: Is correction of the paravaginal defect in anterior vaginal wall prolapse necessary? April 1, 2018

Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose? April 1, 2018

Associations Between Risk Factors and Overactive Bladder: A Meta-analysis. March 25, 2018

Coffee intake, health-related quality of life, and associated factors of overactive bladder in older Korean women living in rural South Korea. March 25, 2018

Increased risk of overactive bladder in patients with idiopathic Parkinson's disease: Insight from a nationwide population-based cohort study. March 25, 2018

Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis. March 24, 2018

Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost. March 24, 2018

Velicept Therapeutics Initiates First of Two Phase 2b Dose-Ranging Studies of Solabegron in Patients with Overactive Bladder; Finalizes Novel, Once Daily Formulation; and Receives U.S. Patent Covering OAB March 19, 2018

Vascular risk factors for male and female urgency urinary incontinence at age 68 years from a British birth cohort study. March 13, 2018

Affective symptoms and quality of life in patients with voiding or storage dysfunction: Results before and after sacral neuromodulation: A prospective follow-up study. March 11, 2018

A blinded observational cohort study of the microbiological ecology associated with pyuria and overactive bladder symptoms. March 11, 2018

Effects of Overactive Bladder Symptoms in Stroke Patients' Health Related Quality of Life and Their Performance Scale. March 11, 2018

Page 1 of 72